Clinical perspectives of TRAIL: insights into central nervous system disorders
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical perspectives of TRAIL: insights into central nervous system disorders
Authors
Keywords
TRAIL, Neuroinflammation, Alzheimer’s disease, Multiple sclerosis, Ischemic stroke, Therapeutic potential, Biomarker
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 73, Issue 10, Pages 2017-2027
Publisher
Springer Nature
Online
2016-02-24
DOI
10.1007/s00018-016-2164-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low serum TNF-related apoptosis-inducing ligand (TRAIL) levels are associated with acute ischemic stroke severity
- (2015) Yang Ho Kang et al. ATHEROSCLEROSIS
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort
- (2015) Rachel Audo et al. ARTHRITIS RESEARCH & THERAPY
- TNF-Related Apoptosis Inducing Ligand in Ocular Cancers and Ocular Diabetic Complications
- (2015) Paolo Perri et al. Biomed Research International
- TRAIL Modulates the Immune System and Protects against the Development of Diabetes
- (2015) Fleur Bossi et al. Journal of Immunology Research
- A new TRAIL in Alzheimer’s disease therapy
- (2015) Dan Frenkel BRAIN
- Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Regulates Hallmark Features of Airways Remodeling in Allergic Airways Disease
- (2014) Adam Collison et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer’s disease
- (2014) Giuseppina Cantarella et al. BRAIN
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development
- (2014) Avraham Ben-Nun et al. JOURNAL OF AUTOIMMUNITY
- Inverse Correlation Between Circulating Levels of TNF-Related Apoptosis-Inducing Ligand and 17β-Estradiol
- (2014) Giorgio Zauli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy
- (2014) Mohamed H. Tawdy et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal
- (2014) Mateus Luz Levandowski et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Tumor necrosis factor-related apoptosis-inducing ligand mediates the resolution of allergic airway inflammation induced by chronic allergen inhalation
- (2014) L Faustino et al. Mucosal Immunology
- Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
- (2014) Manuel A. Friese et al. Nature Reviews Neurology
- Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model
- (2014) Veronica Tisato et al. PLoS One
- Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: A protector or culprit?
- (2014) Wen Cheng et al. VASCULAR PHARMACOLOGY
- Post-ischemic inflammation regulates neural damage and protection
- (2014) Takashi Shichita et al. Frontiers in Cellular Neuroscience
- Ischemic tolerance modulates TRAIL expression and its receptors and generates a neuroprotected phenotype
- (2014) G Cantarella et al. Cell Death & Disease
- Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
- (2014) U Bertsch et al. Cell Death & Disease
- The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement
- (2013) Gianluca Tornese et al. ACTA DIABETOLOGICA
- Circulating levels of TNF-related apoptosis inducing ligand (TRAIL)
- (2013) Giorgio Zauli CLINICAL ENDOCRINOLOGY
- Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients
- (2013) Guangda Xiang et al. CLINICAL ENDOCRINOLOGY
- Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: A cytokine antibody array analysis
- (2013) Shaojia Lu et al. COMPREHENSIVE PSYCHIATRY
- TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
- (2013) C. Gasparini et al. CURRENT MEDICINAL CHEMISTRY
- The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritis
- (2013) Rachel Audo et al. CYTOKINE
- Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis
- (2013) Montserrat Moreno et al. JOURNAL OF NEUROIMMUNOLOGY
- Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL
- (2013) Hodaya Prinz-Hadad et al. Journal of Neuroinflammation
- Leukocyte infiltration in experimental stroke
- (2013) Nina Vindegaard Grønberg et al. Journal of Neuroinflammation
- Structural determinants of DISC function: New insights into death receptor-mediated apoptosis signalling
- (2013) Tamas Sessler et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients
- (2013) Pavel Osmancik et al. PLoS One
- Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol
- (2013) Gloria Brombo et al. PLoS One
- Immunological Profile of Silent Brain Infarction and Lacunar Stroke
- (2013) Paola Sarchielli et al. PLoS One
- TRAIL on trial: preclinical advances in cancer therapy
- (2013) Daniel W. Stuckey et al. TRENDS IN MOLECULAR MEDICINE
- The Importance of Tau Phosphorylation for Neurodegenerative Diseases
- (2013) Wendy Noble et al. Frontiers in Neurology
- Regulation of the human TRAIL gene
- (2012) Joshua E. Allen et al. CANCER BIOLOGY & THERAPY
- TRAIL, a New Weapon against Neointimal Hyperplasia
- (2012) Paola Secchiero et al. CARDIOLOGY
- Multiple Sclerosis: Risk Factors and their Interactions
- (2012) Giulio Disanto et al. CNS & Neurological Disorders-Drug Targets
- Hypoxia-Ischemia Upregulates TRAIL and TRAIL Receptors in the Immature Rat Brain
- (2012) Zhiheng Huang et al. DEVELOPMENTAL NEUROSCIENCE
- Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients
- (2012) A. Bisgin et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pathophysiologic Cascades in Ischemic Stroke
- (2012) Changhong Xing et al. International Journal of Stroke
- TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
- (2012) C. T. Hellwig et al. MOLECULAR CANCER THERAPEUTICS
- State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
- (2012) Stella Bernardi et al. Recent Patents on Anti-Cancer Drug Discovery
- TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer’s Aβ
- (2012) S Fossati et al. Cell Death & Disease
- Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells
- (2011) Sung-Chul Lim et al. CARCINOGENESIS
- The therapeutic potential of TRAIL receptor signalling in cancer cells
- (2011) Rosario Yerbes et al. Clinical & Translational Oncology
- TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice
- (2011) B. A. Di Bartolo et al. DIABETOLOGIA
- Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells
- (2011) Erika Rimondi et al. INVESTIGATIONAL NEW DRUGS
- Role of decoy molecules in neuronal ischemic preconditioning
- (2011) Mathivadhani Panneerselvam et al. LIFE SCIENCES
- A Single Intrathecal Injection of DNA and an Asymmetric Cationic Lipid as Lipoplexes Ameliorates Experimental Autoimmune Encephalomyelitis
- (2011) Srikanth Yellayi et al. MOLECULAR PHARMACEUTICS
- TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis
- (2011) Carlos López-Gómez et al. PLoS One
- The role of cell type-specific responses in IFN- therapy of multiple sclerosis
- (2011) J. A. Zula et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults
- (2010) Stefano Volpato et al. ATHEROSCLEROSIS
- Control of death receptor ligand activity by posttranslational modifications
- (2010) R. Weinlich et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Treatment With Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes
- (2010) G. Zauli et al. DIABETES
- Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy
- (2010) P. Secchiero et al. DIABETIC MEDICINE
- Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells
- (2010) Federica Corallini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dual Effects of TRAIL in Suppression of Autoimmunity: The Inhibition of Th1 Cells and the Promotion of Regulatory T Cells
- (2010) T. Ikeda et al. JOURNAL OF IMMUNOLOGY
- Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation
- (2010) B G Jaganathan et al. LEUKEMIA
- Degeneration and repair in central nervous system disease
- (2010) Eng H Lo NATURE MEDICINE
- The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients
- (2010) S. Liabeuf et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia
- (2010) Min Cui et al. NEUROBIOLOGY OF DISEASE
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction
- (2009) Paola Secchiero et al. ATHEROSCLEROSIS
- Tumor necrosis factor-related apoptosis-inducing ligand and the regulation of hematopoiesis
- (2009) Paola Secchiero et al. CURRENT OPINION IN HEMATOLOGY
- Prognostic value of apoptosis markers in advanced heart failure patients
- (2009) A. Niessner et al. EUROPEAN HEART JOURNAL
- TNF-related apoptosis-inducing ligand level in Alzheimer’s disease
- (2009) Sermin Genc et al. NEUROLOGICAL SCIENCES
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
- (2009) Paola Secchiero et al. PLoS One
- Type I Interferons and Interferon Regulatory Factors Regulate TNF-Related Apoptosis-Inducing Ligand (TRAIL) in HIV-1-Infected Macrophages
- (2009) Yunlong Huang et al. PLoS One
- The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis
- (2009) F. Corallini et al. RHEUMATOLOGY
- Role of full-length osteoprotegerin in tumor cell biology
- (2008) G. Zauli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Letter by Secchiero and Zauli Regarding Article, “Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice”
- (2008) Paola Secchiero et al. CIRCULATION
- Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
- (2008) Avi Ashkenazi NATURE REVIEWS DRUG DISCOVERY
- Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Promotes Migration of Human Bone Marrow Multipotent Stromal Cells
- (2008) Paola Secchiero et al. STEM CELLS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now